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In the recent years, there has been an increase in the number of metabolomic approaches used, in parallel with proteomic and
functional genomic studies. The wide variety of chemical types of metabolites available has also accelerated the use of different
techniques in the investigation of the metabolome. At present, metabolomics is applied to investigate several human diseases, to
improve their diagnosis and prevention, and to design better therapeutic strategies. In addition, metabolomic studies are also being
carried out in areas such as toxicology and pharmacology, crop breeding, and plant biotechnology. In this review, we emphasize
the use and application of metabolomics in human diseases and plant research to improve human health.
1. Introduction
Metabolomics is the comprehensive, nonbiased, high
throughput analysis of complex metabolite mixtures
allowing ideally the identification and quantification of
every individual metabolite. Metabolomics has emerged
as a functional genomics methodology that contributes to
our understanding of the complex molecular interactions
in biological systems [1]. As such, metabolomics represents
the logical progression from large-scale analysis of RNA and
proteins at the systems level [2, 3] but unlike transcripts
and proteins, the highly diverse molecular identity of
metabolites relies on sophisticated instrumentation such as
mass spectrometry (MS) and nuclear magnetic resonance
spectroscopy (NMR) [4] to be determined.
Metabolites are the end products of cellular regulatory
processes, and their levels can be regarded as the ultimate
response of biological systems to genetic or environmental
changes [5]. Metabolites are also highly dynamic in time and
space and show an immense range of structures raising the
challenges for analytical procedures in their measurement
[6].
Metabolomics allows for a global assessment of a cellular
statewithin the context of the immediate environment, taking
into account gene expression, genetic regulation, altered
kinetic activity and regulation of enzymes, and changes
in metabolic reactions [7–9]. Thus, metabolomic studies
compared with genomics or proteomics reflect changes in
phenotype and function of a particular tissue, or organism.
Thus, the omic sciences are used in a complementary manner
to carry out studies in order to characterize a phenotype.The
change in the expression of genes and proteins will surely
produce changes in the metabolic profile of a cell, tissue
or organism [7, 10]. Moreover, metabolomic determinations
offer the same advantages as proteomic and transcriptomic
techniques: they all have the ability to assay biofluids and are
relatively inexpensive, rapid, and automated techniques once
start-up costs are taken into account.
Metabolomics was first applied to the study of toxicology
and pharmacology, inborn metabolic errors, and nutrition
[10]. There is currently great interest in the application of
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Figure 1: Applications of metabolomics.
metabolomics to characterize different pathological states of
human diseases like cancer, diabetes, autoimmune, and coro-
nary diseases. Moreover, metabolomics can provide valuable
tools in a wide range of applications, including microbial
biotechnology, food technology, pharmacology, toxicology,
enzyme discovery, systems biology, and plant biotechnology
(Figure 1). Current research in plants makes extensive use
of metabolomics due to the benefit produced on human
health of various products of plant origin, including food,
pharmaceuticals, and industrial raw materials, as well as its
use in plant breeding and nutrition assessment. In addition,
the vast chemical diversity of plants compared with animals
and microorganisms also contributes to the prominence of
metabolomics in plant research [11].
Recent technological progress in NMR spectroscopy and
MS, the twomost acceptedmethods used in themeasurement
of metabolites, has improved the sensitivity and spectral
resolution of analytic assays on metabolomic samples in
attempts to achieve a comprehensive biochemical measure-
ment. Although not all strategies used in metabolomics are
universally accepted it is however possible to summarize the
most popular ones [19–22] (see Table 1), includingmetabolite
target analysis, metabolite profiling, metabolomics, metabo-
lite flux analysis, andmetabolic fingerprinting (and footprint-
ing).
2. Metabolomics in Human Diseases
One of the most important applications of metabolomics in
the study of human diseases is in the field of oncobiology.
Because tumor cells are highly proliferative and have a
high transcription and translation rates, as well as a higher
energy demand, they have special metabolic requirements
when compared to normal cells and frequently lose many
regulatory functions [35]. Thus, one of the greatest chal-
lenges in medicine is the use of metabolomics in predicting
the appearance of tumor cells. Initially, putative metabolic
biomarkers for cancer detection and/or assessment of efficacy
of anticancer treatment are discovered in preclinical analyses,
followed by the validation of these biomarkers in biofluids
(blood, urine, prostatic secretions, etc.) [36]. At present,
different metabolites have been identified and proposed that
would serve as markers for several tumor processes and
other diseases (see Table 2). However, in most cases the
combination of metabolomics with other genomic and/or
proteomic techniques is extremely useful for both prevention
and diagnosis of cancer.
One of the most frequent tumors with an increasing
incidence in humans is the hepatocellular carcinoma (HCC).
Liu et al. [37] reported the identification of cytokine biomark-
ers using antibody microarrays. They identified several pro-
tein markers such as a macrophage-derived chemokine and
macrophage-stimulating protein differentially expressed in
patients with liver carcinoma. In addition, different stud-
ies were performed in order to obtain a metabolite pro-
file in patients with HCC. Using ultraperformance liquid
chromatography-electrospray ionization andTOFmass spec-
trometry, Patterson et al. [38] have described an alteration
of lipid metabolism in these patients, with an increase
of glycodeoxycholate, deoxycholate-3-sulfate, and bilirubin.
Moreover, the reduction in the levels of lysophosphocholine
correlated with the appearance of HCC. Other metabolites
found to be altered in liver cancer were polar compounds
especially those from the amino acid group such as arginine,
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Table 1: A comparison between the most used methods applied to metabolomic research.
Technique Use Overview References
HPLC-MS a, b, c High sensitivity, nonvolatile metabolites, expensive [12, 13]
GC-MS a, c High sensitivity, only volatile compounds, nonexpensive [14, 15]
NMR b, d, e For highly abundant metabolites, nondestructive, very reproducible, low sensitivity [16]
MS a, b, c, d, e High sensitivity, usually coupled with other techniques [17]
Raman spectroscopy e Low resolution, sensitivity, automated, high throughput [18]
Ref: a: metabolite target analysis; b: metabolite profiling; c: metabolomics; d: metabolite flux analysis; e: metabolic fingerprinting. MS: mass spectrometry;
HPLC-MS: high-performance liquid chromatography-MS; GS-MS: gas chromatography-MS; NMR: nuclear magnetic resonance spectroscopy.
Table 2: Metabolites used as biomarkers of human diseases.
Disease Metabolite biomarker References
Male infertility Citrate, lactate, and glycerylphosphorylcholine [23, 24]
Lung cancer
Metabolites that are shown to have a statistically significant difference between healthy
individuals and lung cancer patients were hippurate, trigonelline, 𝛽-hydroxyisovalerate,
𝛼-hydroxyisobutyrate, N-acetylglutamine, and creatinine
[25]
Alzheimer’s disease
Succinic anhydride, pyruvic acid, 2-aminopropanol, n,n-didemethylchlorpromazine, L-alanine
n-butyl ester, L-glutamic acid dibutyl ester, L-dopa, taurine, creatine, creatinine, lactate,
𝛽-alanine, cysteine, fumaric acid, 2-octenedioic acid, and acetoacetic acid
[26, 27]
Respiratory diseases Asthmatic children: acetate; chronic obstructive pulmonary disease (COPD): leucine, lactate,propionate, acetate, and pyruvate [28, 29]
Huntington disease 3-Nitropropionic acid [30]
Multiple sclerosis Elevated levels: 2-aminobutyrate, 1,3-dimethylurrate, glutamate, and acetate. Reduced levels:oxaloacetate, citrate, alanine, and 3-hydroxybutyrate. [31]
Impaired glucose
tolerance (IGT) Significantly altered levels: glycine, lysophosphatidylcholine (LPC) (18:2), and acetylcarnitine [32]
Renal cell carcinoma Phospholipids, phenylalanine, tryptophan, acylcarnitines, cholesterol metabolites, andarachidonic acid metabolism [33]
Colorectal cancer Acteylcarnine, phenylacetylglutamin, leucylproline, and aspartyllysine [34]
Kidney cancer Quinolinate, 4-hydroxybenzoate, and gentisate [34]
proline, alanine, lysine, and aspartate [39]. In addition, an
increased level of some amino acids (including alanine) was
found in other tumors such as brain tumors, gliomas, and
neuroepithelial tumors [40]. Recently, it was described that
compounds such as choline, phosphocholine, myoinositol,
glycine, taurine and glycerophosphocholine are altered in
some types of breast cancers. In this type of diseases, usually
othermolecules such as the estrogen receptor and theHuman
Epidermal Growth Factor Receptor 2 (Her2/neu) are widely
used as biomarkers for prognostic or predictive purposes [10].
On the other hand, myo-inositol levels were also found to
be increased in prostate cancer, colon adenocarcinoma, and
ovarian carcinoma [41, 42].
The use of stable isotopes in cancer research has also
been reported. Stable isotopes are nontoxic compounds such
as 13C-labeled metabolites which can be used to investigate
metabolic pathways in normal or highly proliferative cells
[43]. Such isotopes can be distinguish easily by NMR or MS
and provide information about changes in the regulation of
biochemical pathways between cancer and noncancer cells,
leading to the development of new diagnostic tools.
However, there are several gaps in the knowledge of the
cancermetabolome.Themetabolite profile could vary among
the different tumor types making it difficult to generalize
findings across tumor groups. There are also technical dif-
ficulties encountered while performing metabolomic assays
that may hinder the characterization of a tumormetabolome,
including sample-to-sample variation, the sensitivity and the
physiological status of the tumor [10].
Another application of metabolomics in the field of
human health includes nutrigenomics. The term nutrige-
nomics is associated with the interaction of the diet and
the genes and reflects the change in gene expression that
takes place after the exposure to different nutrients. The
identification of certain compounds that would have the
ability to act on the expression of target genes is extremely
important in preventing diseases such as cancer. Moreover,
this interaction could influence the absorption, digestion, and
the elimination of metabolites [44]. Thus, the metabolomic
approachmay allow the discovery of bioprotective foods [20].
Finally, metabolomics became indispensable for the iden-
tification and prevention of coronary heart disease. The
recognition of a myocardial ischemic episode is important
for both the diagnosis and therapy of the disease [45]. At
present, several protein and enzyme biomarkers are used for
the identification of patients with risk of coronary diseases
such as reactive C-protein, tumor necrosis factor 𝛼 (TNF-
𝛼), receptors types 1 and 2 (sTNF-R1 and sTNF-R2), and
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interleukin-6 [46]. However, numerous efforts are underway
to identify metabolites that may also serve as markers of
disease using metabolomic techniques. Sabatine et al. (2005)
reported an alteration in the levels of several metabolites that
could serve as biomarkers of myocardial ischemia. Plasma
levels of lactic acid and also metabolites involved in skeletal
muscle AMP catabolism such as hypoxanthine and inosine as
well as alanine were found to be increased after myocardial
injury [47]. On the other hand, several metabolites such
as Krebs cycle intermediates, uric acid, and GABA yielded
significant but discordant changes in controls and cases.Mayr
et al. (2008) used a combined metabolomic and proteomic
approach to study patients presenting persistent atrial fibril-
lation. Those results showed a rise in beta-hydroxybutirate
levels with an increase in different ketogenic amino acids
and glycine [48]. The metabolomic data correlates with the
increase in 3-oxoacid transferase, a key enzyme involved in
ketolytic energy production. Recently, Shah et al. (2010) char-
acterized themetabolic profile of patients with cardiovascular
disease using 69 metabolites [49]. Different acylcarnitines as
well as several amino acid levels including leucine, isoleucine,
glutamate, glutamine, proline, and methionine were found
to be altered in patients when compared to control groups
[49]. In addition, it has been reported that the level of the
metabolite dicarboxylacylcarnitine could be predictive of car-
diovascular disease. More recently, using plasma metabolic
fingerprint, it has been possible to classify patients with aortic
abdominal aneurysm (AAA) and to predict the disease stage.
In this assay, sphingolipids, lysophospholipids, cholesterol,
acylcarnitines, and guanidinosuccinic acid were proposed as
markers of AAA [50].
Although many efforts have been made in order to find
newmetabolicmarkers for the prevention of cardiac diseases,
the metabolomic approach is still under development. To
better understand metabolic pathways alterations, including
changes in metabolite levels and gene transcription taking
place in patients with risk of cardiac disease, it is necessary
to use integrated approaches, combining biomarkers from
genomics, proteomics, andmetabolomics.This will result in a
better picture and therefore a better selection of the potential
biomarkers for prevention, diagnosis, and risk prediction of
heart disease [51].
3. Metabolomics and Its Applications in Plant
Biotechnology
Metabolomics originally developed frommetabolic profiling.
In the early 1970’s GC-MS technologies were used to analyze
steroids, acids, and neutral and acidic urinary drug metabo-
lites [52–54]. Soon afterwards, the concept of usingmetabolic
profiles to screen, diagnose, and assess health began to spread
[55, 56]. However, it was not until the early 1990’s that
metabolite profiling was used to study plant organisms [14,
57, 58].
Plant metabolites are involved in many resistance and
stress responses and also contribute to the color, taste,
aroma, and scent of fruits and flowers [2]. As we mentioned
previously, the biochemical phenotype of an organism is the
final result of interactions between the genotype and the
environmental stimuli; but it is also modulated by intracel-
lular physiological fluctuations that are part of homeostasis
[3]. Thus, the simultaneous identification and quantification
of metabolites is necessary to understand the dynamics of
the metabolome, analyze fluxes in metabolic pathways and
decipher the role of eachmetabolite following various stimuli
[59]. The challenge of metabolomics is to find changes in
biochemical pathways, and metabolic networks that might
correlate with the physiological and developmental pheno-
type of a cell, tissue, or organism [2, 3].
One of the greatest achievements of plant biology is
the completion of the whole genome sequences of model
plants such as Arabidopsis thaliana and rice. In Arabidopsis
∼27000 genes were predicted based on nucleotide sequence
information; however, only half of these genes have been
functionally annotated based on sequence similarity to
known genes, and among these the function of only ∼11% has
been confirmed with direct experimental evidence [60]. The
elucidation of unknown genes function is therefore currently
a major challenge in plant research. Because there is very
little information on the number of genes in a particular gene
family of a nonmodel plant, it becomes necessary to know the
profile of expression of these genes under different conditions
and stimuli. The integration of metabolomics with transcrip-
tional profiles can provide clues for the identification of the
functions of the unknown genes, regardless of whether they
are from model or nonmodel plants [61].
Plants produce more than 200,000 metabolites, many of
which play specific roles in allowing adaptation to specific
ecological niches [5, 62]. Therefore, the main problems
encountered when characterizing the plant metabolome have
to do with the fact that in comparison to the proteome or
transcriptome, the metabolome is highly complex in nature,
due to the enormous chemical diversity of the compounds. In
addition, there is a wide range of metabolite concentrations,
which can vary over nine orders of magnitude (pM to mM).
These large variations in the nature and the concentration of
analytes to be studied provide challenges to all the analytical
technologies employed in metabolomic strategies [63].
Using metabolomics, it is possible to identify pathways
responsible for the production of important foodmetabolites
that could be important in improving human health. There
are several examples where the modification of certain
metabolic pathways led to the production of plants with an
increased nutritional value. This is the case of Golden Rice
(GR), which is genetically modified rice that accumulates
𝛽-carotene in the endosperm [64]. The production of this
variety of rice allowed alleviating vitamin A deficiency, a
major nutritional problem worldwide. The nutritional value
of GRwas later improved by the overexpression of a phytoene
synthase gene leading to the obtention of the GR2 variety,
which accumulates higher amounts of carotenoids (84% of
the total is 𝛽-carotene) [65]. Mehta et al. (2002) were able to
express an S-adenosylmethionine decarboxylase gene under
the inducible E8 promoter in tomato. The transgenic variety
shows higher levels of different polyamines during fruit
ripening, including spermidine and spermine, leading to an
BioMed Research International 5
increase in themetabolite lycopene, which prolonged vine life
and enhanced fruit juice and nutrient quality [66].
Other examples include the engineering of plants to
enhance anthocyanin content. Anthocyanins are flavonoids,
a class of pigments that contribute to the colors and antiox-
idant qualities of plants. Moreover, these metabolites have
been associated with the protection against several human
diseases, but their natural levels in plants are inadequate to
confer optimal benefits. Recently, it has been reported that
the expression of two transcription factors in tomato led to
the accumulation of higher quantities of anthocyanins at con-
centrations comparable to those founded in high antocyanin-
containing plants such as blackberries and blueberries [67].
The new variety has an intense purple coloration and also
a 3-fold enhanced antioxidant capacity. In addition, this
study also reported an extension of the life-span of cancer
susceptible mice which were fed with a diet supplemented
with this tomato variety.
Plant metabolomics is being increasingly used for under-
standing other processes such as the cellular responses
to stress conditions. The metabolic readjustment to sulfur
deficiency is an example of this [74]. A close relationship was
found between sulfur assimilation, nitrogen, lipid, and purine
metabolism and enhanced photorespiration. Metabolomics
has also been applied to the study of the cold stress response
[75]. Other applications include metabolic engineering of
biochemical pathways, gene function discovery, and engi-
neering pathways for pharmaceuticals production (Table 3)
[76].
4. Methods Used for the Determination of
Plant Metabolomes
The basic instrumentation useful for the evaluation of plant
metabolome includes direct spectroscopy, chromatography
(fingerprinting), or high-performance chromatography (GC
or HPLC) combined with spectroscopy (IR, NIR, MS).
The coupling of chromatographic methods with MS can
substantially increase the depth ofmetabolome coverage, add
an additional dimension for metabolite identification and
enhance the biological context through the more rigorous
identification of a greater number of metabolites [77].
GC-MS is one of the most widely used analytical tech-
niques in plant metabolomics. It is utilized to analyze a
qualitatively and quantitatively wide range of volatile and/or
derivatized nonvolatile metabolites with high thermal sta-
bility. After separation, the eluted metabolites are identified
by mass spectrophotometers. This technique has high ana-
lytical reproducibility and lower costs compared to other
hyphenated techniques, such as LC-MS or LC-NMR [15, 77].
Alternatively, direct injectionMS analysismay also be applied
for the phenotyping of plants, that is, Fourier transformed-
MS (FT-MS) provides ultimate limit of detection and mass
measurement precision to enable metabolomic analyses [77,
78].
In the last years, the use of LC-MS in plant metabolomics
has been increasing. LC-MS is more suitable than GC-MS
for labile compounds as well as for those that are difficult to
derivatize. The application of LC-MS in plant metabolomics
includes the description of the tomato metabolome database
(MoTo DB) [79], the identification of the accumulation of
oxylipins after wound-induced stress in Arabidopsis [80], the
identification of flavonoid and isoflavonoid compounds in
Medicago truncatula [81], the untargeted large-scale analysis
of plant metabolome [82], the characterization of metabolites
that respond to stress [83, 84], and the identification of
flavonoid glycoconjugates in roots formMedicago truncaluta
[85].
Another technique used for the quantitative analysis of
plant metabolites is capillary electrophoresis coupled to MS
(CE-MS) [86]. CE-MS was used to characterize the amino
acid profile in plant cell cultures [87], to characterize the
metabolome of bacterial-infected orange leaves [88], and to
identify the metabolite profile in Illicium anisatum [89]. CE
coupled with MS has also the advantages of high resolution
and high reliability [86].
Fourier transformed infrared spectroscopy (FT-IR), near
infrared resonance (NIR) Raman spectroscopy, and, more
recently, nuclear magnetic resonance (NMR) spectroscopy
are constantly developing rapid, nondestructive and high-
throughput techniques for a diverse range of sample types.
FT-IR has also been introduced as a metabolic fingerprint-
ing technique within the plant sciences [90, 91]. Raman
spectroscopy coupled with microscopy has been recently
used with great success, making possible the identification
and quantification of phytochemicals and their distribution
directly from plant tissues [92–94].
NMR techniques can uniquely identify and simultane-
ously quantify a wide range of organic compounds in the
micromolar range [95, 96]. NMR-based methods can be
broadly classified into solution NMR and insoluble or solid-
stateNMR, according to sample solubility. In onedimensional
NMR, protons (1H) are usually observed (1H-NMR) due
to the sensitivity and common occurrence of this magnetic
nucleus. More detailed analyses, such as metabolite iden-
tification or flux assay, can be obtained with other nuclei,
particularly 13C and 15N that are coupled with 1H nuclei
in twodimensional or multidimensional NMR analysis [97,
98]. Recently, NMR has been used to identify secondary
metabolites involved in host-plant resistance [99] and to
characterize the metabolites produced after salt stress expo-
sure in maize plants [100]. Other applications of NMR are in
the investigation of food quality and in the standardization
and control of different phytomedical preparations [101].
The resulting MS or NMR spectra are preprocessed to
suppress noise and align the different peaks. Thereafter, the
data are used to identify the different metabolites present in
the sample usingmetabolite databases. In nontarget analyses,
the spectra of unknown compounds can be subjected to
statistical analyses [102]. In target analyses, the sets of spectral
data that are associated with particular compounds are used
as metabolic profiles for each compound in further analyses
[102].
All themetabolomic technologiesmentioned require data
processing analysis due to, for example, some inaccuracies
such as chromatogram shift and mass drift. Some of the
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Table 3: Recent applications of metabolomics in plant biotechnology.
Organism Application Technology used Reference
Catharanthus roseus Improvement of the production of anticancer indole alkaloid byoverexpression of ORCA3 and G10H in C. roseus plants NMR [68]
Panicum
virgatum (switchgrass)
Increased amounts of phenolic acids and a monolignol analog
associated with more facile cell wall deconstruction GC-MS [69]
Solanum tuberosum (L) Increased drought tolerance by expression of trehalose-6-phosphatesynthase 1 GC-MS [70]
Oryza sativa Modulation of salt tolerance by reduction of OsSUT1 (O. sativasucrose transporter 1) expression GC-TOF-MS [71]
Arabidopsis thaliana Distinguish transgenic and nontransgenic plants NMR [72]
Solanum Lycopersicum Higher accumulation of flavonoids and thus nutritional value intomato plants carrying a mutation in HP1/LeDDB1 gene LC-ESI-MS/MS [73]
most used methods to group metabolites in samples include
multivariate statistical analyses such as principal compo-
nent analysis (PCA), hierarchical clustering analysis (HCA),
and self-organization mapping (SOM) [102]. In addition,
the analysis and comprehension of the data obtained by
metabolomics is often integratedwith data from genomic and
proteomic experiments [102].
5. Metabolomic Resources
Several metabolomic resources and metabolite databases
are available (Table 4). The Human Metabolome Database
is an electronic database which contains information on
metabolites found in humans (http://www.hmdb.ca/). This
database includes chemical, clinical, and biochemical
data, linking known metabolites to several genes
and proteins. The Golm Metabolome Database
(http://gmd.mpimp-golm.mpg.de/) contains information
about mass spectra from active metabolites quantified
by GS-MS. The Madison Metabolomics Database1
is a resource for metabolomics research based on
NMR and MS (http://mmcd.nmrfam.wisc.edu/).
Another integrative database is Metabolights
(http://www.ebi.ac.uk/metabolights/). This database2
is cross-species and contains information about
metabolite structures, spectra and biological roles.3
Metabolomics at Rothamsted (MeT-RO) is an
initiative that contains several resources that can
be applied to plant and microbial metabolomics
(http://www.metabolomics.bbsrc.ac.uk/MeT-RO.htm).
The Metlin Metabolite Database contains information
on about 55,000 metabolites and nearly 50,000 high
resolution MS/MS spectra and tandem MS experiments
(http://metlin.scripps.edu/). PRIMe, a platform for RIKEN
metabolomics is a database that integrates genomic and
metabolomic data. It contains information on metabolites
obtained from NMR spectroscopy, GC-MS, LC-MS, and
CE-MS (http://prime.psc.riken.jp/).
Several databases for plant species have also
been developed, such as Plantmetabolomics
(http://plantmetabolomics.vrac.iastate.edu/ver2/). This
initiative started as a metabolomic and functional
genomic tool for elucidating the functions of Arabidopsis
genes. In addition, other databases such as the
Metabolome Tomato Database are available and contain
information on metabolites identified by LC-MS
(http://appliedbioinformatics.wur.nl/moto/). A related
database is Terpmed (https://www.terpmed.eu/) which
contains information about plant terpenoids, natural 4
products, and other secondary metabolites important for
use as therapeutic drugs. The Armec Repository Project
was created as a tool to annotate flow injection electrospray
MS (FIE-MS) data, but information about HPLC-ESI-
MS can also be found in this database. Moreover, at
present the Armec database is in expansion, including
information about additional species focused on food
crops and human metabolome for use in nutrition research
(http://www.armec.org/MetaboliteLibrary/).
On the other hand, there are several resources that
integrate metabolite data with metabolic pathways
such as MetaCyc (http://metacyc.org/) that contains
information on about 1800 pathways from more than
2000 organisms. Other related databases are RiceCyc
(http://pathway.gramene.org/gramene/ricecyc.shtml),
AraCyc (http://www.arabidopsis.org/biocyc/),
Solanacea Genomics Network (SolCyc,
http://solgenomics.net/tools/solcyc/index.pl), HumanCyc
(http://humancyc.org/), KEGG Pathway database
(http://www.genome.jp/kegg/pathway.html), and Mapman
(http://mapman.gabipd.org/web/guest/mapman).
6. Conclusions
Metabolomic studies require knowledge in many areas such
as biochemistry, biology, physiology, and bioinformatics.
Metabolomics has the potential to make a large impact on
different areas of biology, including human health, plant
biotechnology, toxicology, and pharmacology, among others.
The analysis and comprehension of the data obtained require
the use of bioinformatics, as well as the integration with data
obtained from genomic and proteomic analyses.
With the development of more sensitive technologies
and also computational tools for statistical analysis and data
interpretation, metabolomics has the potential to help us
better understand the molecular mechanisms of disease.
In addition, the identification and characterization of new
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Table 4: Metabolomic resources.
Name URL Information/Species
Human metabolome database http://www.hmdb.ca/ Chemical and biological data of humanmetabolites
Golm metabolome database http://gmd.mpimp-golm.mpg.de/ GS-MS
Madison metabolomics database http://mmcd.nmrfam.wisc.edu/ NMR and MS
Metabolights http://www.ebi.ac.uk/metabolights/ Metabolite structures, spectra,function/cross-species
Metabolomics at Rothamsted
(MeT-RO) http://www.metabolomics.bbsrc.ac.uk/MeT-RO.htm Plant and microbial metabolites
Metlin metabolite database http://metlin.scripps.edu/ High resolution MS/MS spectra andtandemMS experiments
PRIMe http://prime.psc.riken.jp/
Genomic and metabolomics data/NMR
spectroscopy, GC-MS, LC-MS and
CE-MS
Plantmetabolomics http://plantmetabolomics.vrac.iastate.edu/ver2/ Arabidopsis and other plant species
Metabolome tomato database http://appliedbioinformatics.wur.nl/moto/ Metabolites identified by LC-MS
Terpmed https://www.terpmed.eu/ Plant terpenoids, natural products,secondary metabolites/Therapeutic drugs
Armec repository project http://www.armec.org/MetaboliteLibrary/ FIE-MS/HPLC-ESI-MS data/human andplant metabolomes for nutrition
MetaCyc http://metacyc.org/ Integration of metabolite data withmetabolic pathways/2000 organisms
RiceCyc http://pathway.gramene.org/gramene/ricecyc.shtml Metabolic pathways, enzymes,metabolites
AraCyc http://www.arabidopsis.org/biocyc/ Metabolic pathways,compounds/Arabidopsis
Solanacea Genomics network
(SolCyc) http://solgenomics.net/tools/solcyc/index.pl
Pathway genome databases/solanacea
species
HumanCyc http://humancyc.org/ Metabolic pathways, genome/human
KEGG Pathway database http://www.genome.jp/kegg/pathway.html
Pathways, metabolism, genetic
information Cellular processes, human
diseases
Mapman http://mapman.gabipd.org/web/guest/mapman Datasets (e.g., Gene expression data,metabolic pathways
biomarkers will allow the diagnosis and prevention of many
diseases, as well as the discovery of new drugs. However, in
most diseases the analysis of other biomarkers, like protein
markers as well as the evaluation of the physiological state for
diagnosis and treatment is also required.
In the area of plant biotechnology, metabolomics,
together with genomic and proteomic studies, has identi-
fied new genes or genes with new functions. In this area,
metabolomics has gained importance in the evaluation of
transgenic plants, food quality, the increase disease resistance,
and herbicide or salinity tolerance. Moreover, the integration
of the three omics and systems biology is an excellent strategy
for the discovery enzymes involved in unknown metabolic
pathways. In addition, metabolomics applied to the study
of plants becomes extremely important in the efforts that
are performed in order to improve human health. As there
are several examples where the manipulation of different
metabolic pathways led to an increase in the production of
a particular metabolite, the modification of plant metabolic
pathways could lead to the production of new drugs that
could be used for the treatment of many diseases.
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